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Italy. To analyze patterns of multimorbidity, a cluster analy-
sis was performed including the same diseases (19 chronic 
conditions with a prevalence >5%) collected at hospital dis-
charge during the two waves of the registry.  Results: Eight 
clusters of diseases were identified in the first wave of the 
REPOSI registry and six in the second wave. Several diseases 
were included in similar clusters in the two waves, such as 
malignancy and liver cirrhosis; anemia, gastric and intestinal 
diseases; diabetes and coronary heart disease; chronic ob-
structive pulmonary disease and prostate hypertrophy. 
 Conclusion: These findings strengthened the idea of an as-
sociation other than by chance of diseases in the elderly 
population.  Copyright © 2013 S. Karger AG, Basel 
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 Abstract 
 Background: As chronicity represents one of the major 
challenges in the healthcare of aging populations, the un-
derstanding of how chronic diseases distribute and co-oc-
cur in this part of the population is needed.  Objectives: The 
aims of this study were to evaluate and compare patterns of 
diseases identified with cluster analysis in two samples of 
hospitalized elderly.  Methods: Data were obtained from the 
multicenter ‘Registry Politerapie SIMI (REPOSI)’ that includ-
ed people aged 65 or older hospitalized in internal medicine 
and geriatric wards in Italy during 2008 and 2010. The study 
sample from the first wave included 1,411 subjects enrolled 
in 38 hospitals wards, whereas the second wave included 
1,380 subjects in 66 wards located in different regions of 
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 Introduction 
 As chronicity represents one of the major challenges 
in the healthcare of aging populations, the understanding 
of how chronic diseases distribute and co-occur in this 
part of the population is really valuable. In the last decade, 
a quantitative assessment of multimorbidity (e.g. evalua-
tion of the coexistence of multiple chronic diseases in the 
same person,  whichever they are) has been done because 
it is necessary and functional in order to quantify the di-
mension of the problem at a population level and to grab 
the attention of healthcare providers  [1] . Nevertheless, 
the exclusive use of a quantitative approach to this phe-
nomenon fails to catch different patterns of coexisting 
diseases, potentially leading to inadequate care manage-
ment. Advancement in the field may be represented by 
the development of a ‘qualitative analysis’ of multimor-
bidity, in terms of how different diseases distribute and 
aggregate in the population, and a ‘cluster medicine’ ap-
proach, in terms of the identification of  specific disease 
clusters, defined as the co-occurrence of two or more spe-
cific chronic diseases in the same persons  [2] . Indeed, it 
has been shown that complex information, such as mul-
timorbidity, can be better recognized as patterns  [3] . 
Clusters can be identified using different statistical tools, 
such as the multimorbidity coefficient, which is the ratio 
of the observed co-prevalence to the expected one (prev-
alence of the diseases if they are completely independent) 
of a set of diseases. This coefficient tells us the degree to 
which the co-morbid diseases exceed the chance level. 
However, in order to have a complete picture of how dis-
eases distribute and co-occur in a population, there is a 
more informative method that can be used, called  cluster 
analysis ; clustering is simply the grouping of similar ob-
jects by using algorithms and different measures of simi-
larity in order to group variables with the highest associa-
tion.
 The aim of this study was to evaluate and compare pat-
terns of diseases identified with cluster analysis in two 
populations of hospitalized elderly. Data were obtained 
from the ‘Registry Politerapie SIMI (REPOSI)’ collected 
during 2008 and 2010 in internal medicine and geriatric 
wards in Italy.
 Methods 
 Data Collection  
 The REPOSI (Registro Politerapie SIMI) is a collaborative ef-
fort between the Italian Society of Internal Medicine (SIMI) and 
the Mario Negri Institute of Pharmacological Research (Milan). 
The REPOSI was designed with the purpose of creating a network 
of internal medicine and geriatric wards in order to evaluate pa-
tients affected by multiple diseases and prescribed with polyther-
apy. Participation in the network was on a voluntary basis, but in 
the choice of the participating centers, attention was given to 
their homogeneous composition in terms of geographic distribu-
tion, size, and unselected admissions from the territory or the 
emergency room. The specific aims of the REPOSI study were: to 
describe the prevalence of co-occurring multiple diseases and 
treatments in hospitalized elderly patients, to correlate clinical 
characteristics of the patients with type and number of diseases 
and treatments, and to evaluate the main clinical outcomes at 
hospital discharge. The original study design included two phas-
es: phase one was designed to create the network of internal med-
icine and geriatric wards, and phase two was intended to activate 
a registry of patients included in the study. All of the patients 
admitted to the wards participating in the study were recruited 
consecutively if they were 65 years old or older. Participation in 
the study was voluntary and an informed consent was signed by 
all the patients  [4] .
 The first wave of the REPOSI register was held between Janu-
ary and December 2008 in 38 hospitals located in different re-
gions of Italy. A sample of at least 40 patients consecutively ad-
mitted to each participating center during a period of 4 weeks, 3 
months apart each from the other (one in February, one in June, 
one in September, and one in December, 2008) was included in 
the study. A standardized web-based case report form was filled 
in by the attending physicians, including socio-demographic fac-
tors, clinical parameters, diagnoses and treatments at both hos-
pital admission and discharge, clinical events during hospitaliza-
tion, and outcome. The initial study sample included 1,411 sub-
jects. Of these, 79 (5.6%) were excluded due to missing or 
incomplete data, 25 had missing data on hospital outcome, and 
54 on socio-demographic and clinical characteristics due to er-
rors in data input and recording; 66 patients died during hospi-
talization, and 111 were transferred to other hospital units. 
Hence, 1,155 individuals from the first wave were available for 
the present analyses.
 The second wave was conducted between January and De-
cember 2010 in 66 hospitals wards located in different regions of 
Italy. A sample of at least 20 patients consecutively admitted to 
each participating hospital during a period of 4 weeks, 3 months 
apart each from the other (one in February, one in June, one in 
September, and one in December 2010) was enrolled in the 
study. The initial study sample included 1,380 subjects. Of these, 
120 (8.6%) were excluded because they were transferred to other 
hospital wards and 50 (3.6%) died during hospitalization; 37 had 
missing information. Hence, 1,173 individuals from the second 
wave were available for the analyses. All the data recorded in the 
net were collected and checked by a central monitor institution 
(the Mario Negri Institute for Pharmacological Research, Mi-
lan). The study was approved by the Ethical Committee of the 
IRCCS Cà Granda Maggiore Policlinico Hospital Foundation, 
Milan.
 Assessment of Diseases 
 Diseases examined in this study were collected at hospital dis-
charge after clinical examination, medical history, and laboratory 
and instrumental data were compiled and performed by the at-
tending physicians. Diagnoses were made using standardized cri-
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teria. The International Classification of Diseases, Ninth Revision 
(ICD-9)  [5] was used for classifying all the diseases. The following 
ICD-9 codes were employed (corresponding diseases are listed in 
alphabetical order): 280–285 (anemia), 300 (anxiety), 715 (arthri-
tis), 427 (atrial fibrillation, AF), 430–438 (cerebrovascular diseas-
es, CVD), 410–414 (coronary heart disease, CHD), 490–496 
(chronic obstructive pulmonary disease, COPD), 585 (chronic re-
nal failure, CRF), 290 and 331 (dementia), 250 (diabetes mellitus), 
272 (dyslipidemia), 530–536 (gastric diseases), 428 (heart failure, 
HF), 401–405 (hypertension), 560–569 (intestinal diseases), 571 
(liver cirrhosis), 140–165, 170–175, and 179–208 (malignancy), 
600 (prostate hypertrophy), and 240–246 (thyroid diseases). Only 
diseases with a prevalence of at least 5% (n = 19) were taken into 
account in this study.
 Statistical Analysis  
 In order to analyze different patterns of multimorbidity, with-
out any a priori hypothesis, a cluster analysis  [6] was performed 
including the same diseases (chronic diseases with a prevalence at 
discharge >5%) during the two waves of the registry. With cluster 
analysis is possible to go beyond the simple pairs of diseases and 
considering how diseases tend to occur in conjunction with each 
other. The aim is to obtain a complete picture of the distribution 
of diseases in the population and identify where a specific disease 
appears in the patterns. It is an exploratory data analysis that gives 
insights into the structure of a dataset and may lead to hypotheses 
for further investigations. It is best seen as hypothesis-generating 
rather than -solving. Cluster analysis is a multivariate statistical 
technique; clustering is the grouping of similar objects by using 
algorithms in order to minimize the ‘logical distance’ inside each 
group and maximize it between groups. The logical distance is cal-
culated according to measure of similarity/dissimilarity amongst 
variables. For the purpose of this study an agglomerative hierarchi-
cal cluster analysis was performed. A correlation matrix was com-
puted among all the diseases using the Yule Q measure of similar-
ity (a similarity measure for binary data that weighs up the number 
of positive matches and the number of negative matches) and av-
erage linkage as algorithm. The dendrograms resulting from the 
two cluster analyses were compared. The distribution of diseases 
seen in different clusters should be significantly different from ran-
dom distribution.
 Results 
 REPOSI, First Wave 
 Of the 1,155 patients that were included in the analy-
ses, 53.6% were females. The median age of the patients 
was 79 years (65–101). The main characteristics of the 
patients, including reasons for hospital admission, are de-
scribed in  table 1 . The most frequent diagnoses at hospital 
admission were: hypertension (60.6%), diabetes mellitus 
(27.0%), CVD (26.5%), CHD (25.5%), AF (25.0%), and 
COPD (21.7%) ( table 2 ).
 The aggregation of diseases was tested by using cluster 
analysis, and eight clusters were identified. Five clusters 
included two diseases: one liver cirrhosis and malignancy, 
one COPD and prostate hypertrophy, one diabetes and 
CHD, one dementia and arthritis, and one thyroid dys-
function and anxiety. Three clusters included three condi-
tions: one anemia, gastric diseases and intestinal diseases, 
one HF, AF and CRF, and one hypertension, dyslipidemia 
and CVD ( fig. 1 ).
Table 1.  Main characteristics of participants at the first (2008) and 
second (2010) wave of REPOSI
First wave 
2008
Second wave 
2010
Number 1,155 1,173
Age, years, median 79 (65–101) 79 (65–100)
Female, % 53.6 48.2
Education, years, mean (SD) 6.4 (2.3) 7.1 (4.1)
Most frequent reasons for hospital admission
Dyspnea, % 6.1 8.5
Pain, % 6.1 7.7
Anemia, % 6.1 6.0
Heart failure, % 6.0 7.3
Syncope, % 3.5 4.5
Fever, % 3.2 4.9
Table 2.  Prevalence (per 100) of diseases in the first and second 
waves of the REPOSI
Diseases First wave 
2008
Second wave 
2010
p
Hypertension 60.6 78.1 <0.001
Diabetes mellitus 27.0 27.2 0.921
Cerebrovascular disease 26.5 21.6 <0.01
Coronary heart disease 25.5 24.1 0.458
Atrial fibrillation 25.0 24.7 0.720
Chronic obstructive
pulmonary disease 21.7 25.2 0.05
Anemia 20.0 12.9 <0.001
Malignancy 19.7 17.3 0.160
Heart failure 18.6 19.1 0.766
Gastric diseases 17.1 24.9 <0.001
Chronic renal failure 14.5 17.1 0.06
Dyslipidemia 13.8 9.5 <0.001
Gut diseases 11.1 13.9 <0.05
Thyroid diseases 10.8 11.1 0.841
Liver cirrhosis 10.6 10.9 0.890
Dementia 9.1 7.5 0.190
Anxiety 8.4 9.4 0.451
Prostate hypertrophy 8.2 12.1 <0.01
Arthritis 7.5 9.9 <0.05
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 REPOSI, Second Wave 
 Of the 1,173 patients that were included in the analy-
ses, 48.2% were females. The median age of the patients 
was 79 years (65–100). The main characteristics of the 
patients are described in  table 1 . The most frequent diag-
noses at hospital admission were: hypertension (78.1%), 
diabetes mellitus (27.2%), CHD (24.1%), AF (24.7%), 
COPD (25.2%), and CVD (21.6%) ( table 2 ). In the second 
wave, the prevalence of hypertension, gastric and gut dis-
eases, prostate hypertrophy and arthritis was significant-
ly higher than the one found in the first wave; on the con-
trary, the prevalence of CVD, anemia and dyslipidemia 
was significantly lower ( table 2 ).
 Six clusters were identified using cluster analysis. One 
included only two diseases, liver cirrhosis and malignan-
cy; three clusters included three diseases: one diabetes, 
CHD and dyslipidemia, one hypertension, thyroid dys-
function and AF, and one CVD, dementia and arthritis. 
Two clusters included four diseases: one anemia, gastric 
diseases, gut diseases and anxiety and one HF, CRF, 
COPD and prostate hypertrophy ( fig. 2 ).
 Several diseases were included in similar clusters in 
the two phases, such as malignancy and liver cirrhosis; 
anemia, gastric and intestinal diseases; diabetes and 
CHD; COPD and prostate hypertrophy. The main dif-
ferences were that in the second wave, CVD aggregated 
with dementia instead of hypertension and dyslipid-
emia, and HF and CRF with COPD instead of AF; on the 
contrary, dyslipidemia aggregated with diabetes and 
CHD, and AF with thyroid dysfunction and hyperten-
sion. An example of comparison between clusters iden-
tified in the REPOSI first and second wave is shown in 
 figure 3 .
 Discussion 
 Despite the increasing prevalence of chronic condi-
tions with age, knowledge about how diseases distribute 
or co-occur in the same individual is limited  [7] . Our 
knowledge is incomplete because few studies have at-
tempted to describe the overall pattern of diseases and 
because alternative methods have been used making find-
ings from different studies difficult to match up.
 In the present study, a cluster approach was employed 
in order to evaluate and compare the distribution of dis-
eases in two samples of hospitalized elderly across Italy in 
different time periods.
 Eight clusters of diseases were identified in the first 
wave and six in the second wave. Several diseases were 
included in similar clusters in the two phases, such as ma-
lignancy and liver cirrhosis; anemia, gastric and intestinal 
diseases; diabetes and CHD; COPD and prostate hyper-
trophy. The main differences were that in the second 
wave, CVD aggregated with dementia instead of hyper-
tension and dyslipidemia, and HF and CRF with COPD 
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 Fig. 1. Dendogram resulting from cluster 
analysis testing the distribution and aggre-
gation of diseases in the REPOSI first wave 
(2008). 
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instead of AF; on the other hand, dyslipidemia aggregated 
with diabetes and CHD, and AF with thyroid dysfunction 
and hypertension.
 One possible explanation of the differences amongst 
clusters found in wave 1 and 2 probably relies in the dif-
ferent number and types of participating hospital units 
between the two phases of the study. This implies not only 
a difference in the prevalence of some chronic diseases, 
but also in admission policies that may vary from hospital 
to hospital. Besides, the meaningfulness of the distribu-
tion of diseases in patterns was maintained in both waves. 
For example, in the second wave, CVD aggregated with 
dementia and it is well known that vascular cerebral pa-
thology can lead to cognitive impairment, especially in 
elderly people; dyslipidemia aggregated with CVD in the 
first and with CHD in the second wave being a risk factor 
for both the above vascular diseases.
 Other studies have used the clustering approach in or-
der to identify groups of associated diseases, in American 
 [6] , Swedish  [8] , and German  [9, 10] adult and elderly 
people, but since now, research on diseases clusters has 
been mostly explanatory of the distribution and co-oc-
currence of diseases in a specific population. However, 
several potential uses of a cluster medicine approach de-
serve to be highlighted:
 (1) New research hypotheses on possible shared path-
ological pathways for clusters of specific diseases can be 
developed. Differences in disease patterns may indicate 
differences in the biological process, environment or 
healthcare quality  [11] . Nakauchi et al.  [12] studied the 
relationship between chronic glomerulonephritis and in-
fections and identified different clusters of immune re-
sponsiveness probably associated with different risks of 
graft rejection. Our findings showed an association be-
tween COPD and prostate hypertrophy in both waves. 
Despite this result they may depend on the higher preva-
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 Fig. 2. Dendogram resulting from cluster 
analysis testing the distribution and aggre-
gation of diseases in the REPOSI second 
wave (2010). 
Anemia
Gastric diseases
Intestinal diseases Anxiety
Thyroid
dysfunction
 Fig. 3. Example of comparison of clusters of diseases identified in 
the REPOSI first and second waves. Shaded areas indicate clusters 
identified in the first wave (2008) and black ellipse indicates clus-
ters identified in the second wave (2010) of the registry. In the first 
wave, anemia, gastric and intestinal diseases were included in one 
cluster and anxiety and thyroid dysfunction in a different cluster; 
in the second wave, anxiety were included in the same cluster as 
anemia, gastric and intestinal diseases. 
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lence of COPD in elderly men and the hypothesis of a 
genetic common pathway, already demonstrated for 
COPD and prostate cancer  [13] , might be deepened also 
for COPD and prostate hypertrophy.
 (2) Prevention, especially secondary prevention, can 
be implemented. In our study, we found patterns of dis-
eases, some of which could be better targeted for second-
ary prevention, such as hypertension, dyslipidemia and 
CVD.
 (3) Groups of people at high risk of adverse outcomes 
(e.g. disability or polypharmacy) can be identified. Previ-
ous findings from the REPOSI registry showed that spe-
cific clusters of diseases had a different impact on mortal-
ity and adverse clinical events during hospitalization  [14] . 
Patients suffering from concurrent anemia and CRF had 
an additive risk of in-hospital death, whereas patients af-
fected by HF and CRF had an additive risk of adverse 
events compared to their pairs affected by only one of the 
above diseases  [14] .
 (4) The prevalence of use of potentially inappropriate 
medication or adverse drug reactions could be higher in 
different clusters. In a previous analysis of the REPOSI 
data, we found different degrees of association of spe-
cific clusters with prescription of polypharmacy at hos-
pital discharge  [15] . Besides, the mean number of pre-
scribed drugs at hospital discharge ranged from 5.7 to 
8.7 according to different disease clusters  [15] .
 (5) Financial resources could be better distributed, in 
fact costs for specific clusters of diseases may be additive 
or multiplicative. Cluster analysis methods can be lever-
aged to develop targeted care management interven-
tions designed to improve health outcomes. Newcomer 
et al.  [16] used cluster analysis for identifying subpopu-
lations of complex patients who may benefit from tar-
geted care strategies.
 (6) Ideally, once the triggering event (i.e. the onset of 
a specific disease) that promotes the clustering with other 
diseases has been identified, trials may be designed in or-
der to change the chain of events. Moreover, clinical trials 
could be carried out in groups of elderly affected by spe-
cific clusters of diseases, e.g. the most easy/difficult to 
treat, the most expensive to treat or the ones with the best 
cost-effectiveness ratio  [17] .
 (7) Finally, the severity of a disease can be approxi-
mated by its connections with other diseases for patients 
with the same number of diagnoses.
 Major strengths of the REPOSI registry are the mul-
ticenter design that involved 38 and 66 internal medi-
cine and geriatric wards throughout Italy respectively 
during 2008 and 2010, resulting in a sample representa-
tive of the hospitalized elderly population in the coun-
try, and the inclusion of the patients during a period of 
4 weeks (one per season) in order to balance the effect 
of seasons on acute diseases leading to hospitalization. 
However, a few limitations need to be mentioned. First, 
problems can arise by using hospital data for research 
purposes, because hospital records are not designed for 
research purposes but rather for patient care and their 
diagnostic quality may vary depending on different hos-
pitals, physicians and clinical units. Second, hospital ad-
missions are often selective on the basis of ward charac-
teristics, severity of disease, associated medical condi-
tions and admission policies that may vary from 
hospital to hospital. This could explain why the preva-
lence of some diseases was significantly different be-
tween waves 1 and 2, as in wave 2 the number of par-
ticipating centers almost doubled. Finally, applying the 
cluster approach to the geriatric population has some 
limitation itself, such as the large number of partici-
pants required and, in this study, the cross-sectional de-
sign that does not allow conclusions regarding causal 
relationships among disease clusters. Moreover, unlike 
many other statistical procedures, cluster analysis meth-
ods are mostly used when researchers do not have any 
a priori hypothesis, but are still in the exploratory phase 
of research. In a sense, cluster analysis finds ‘the most 
significant solution’ possible. Therefore, statistical sig-
nificance testing is not appropriate. Instead ‘external 
stability’ can be measured when small changes in the 
input data (such as little difference in prevalence of dis-
eases) lead to only small changes in the classification 
achieved. The neighborhood of clusters, together with 
the vertical distances of the ramifications, is a measure 
of their similarities  [3] .
 In conclusion, eight clusters of diseases were identi-
fied in the first wave of the REPOSI registry and six in 
the second wave. Several diseases were included in sim-
ilar clusters in the two phases, such as malignancy and 
liver cirrhosis; anemia, gastric and intestinal diseases; 
diabetes and CHD; COPD and prostate hypertrophy. 
These findings strengthened the idea of an association 
other than by chance of diseases in the elderly popula-
tion.
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 Investigators and co-authors of the REPOSI (REgistro POlit-
erapie SIMI, Società Italiana di Medicina Interna) Study Group are 
as follows:
 Steering Committee: Pier Mannuccio Mannucci (Chair, Fon-
dazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Mila-
no), Alessandro Nobili (co-chair, Istituto di Ricerche Farmaco-
logiche ‘Mario Negri’, Milano), Mauro Tettamanti, Luca Pasina, 
Carlotta Franchi (Istituto di Ricerche Farmacologiche ‘Mario Ne-
gri’, Milano), Francesco Salerno (IRCCS Policlinico San Donato 
Milanese, Milano), Salvatore Corrao (ARNAS Civico, Di Cristina, 
Benfratelli, Palermo), Alessandra Marengoni (Spedali Civili di 
Brescia, Brescia), Alfonso Iorio (McMaster University, Hamilton, 
Ont., Canada), Maura Marcucci (Azienda Ospedaliera Santa Ma-
ria della Misericordia, Perugia).
 Clinical Data Monitoring and Revision: Valentina Spirito, Da-
mia Noce, Jacopo Bonazzi, Rossana Lombardo, Eleonora Sparacio, 
Stefania Alborghetti (Istituto di Ricerche Farmacologiche ‘Mario 
Negri’, Milano).
 Database Management and Statistics: Mauro Tettamanti, Luigi 
De Vittorio, Codjo Djignefa Djade (Istituto di Ricerche Farmaco-
logiche ‘Mario Negri’, Milano).
 Investigators: Giuseppe Paolisso, Maria Rosaria Rizzo, Maria 
Teresa Laieta (Azienda Ospedaliera Universitaria della Seconda 
Università degli Studi di Napoli, Napoli, VI Divisione di Medicina 
Interna e Malattie Nutrizionali dell’Invecchiamento); Torella Ro-
berto, Marcello Persico, Teresa Salvatore, Ferdinando Carlo Sasso 
(Azienda Ospedaliera Universitaria della Seconda Università de-
gli Studi di Napoli, Napoli, Medicina Interna e Malattie Epato-
Bilio Metaboliche Avanzate); Riccardo Utili, Emanuele Durante 
Mangoni, Daniela Pinto (Azienda Ospedaliera Universitaria della 
Seconda Università degli Studi di Napoli, Napoli, Medicina Infet-
tivologica e dei trapianti); Luigi Fenoglio, Chiara Brignone, Chris-
tian Bracco (Azienda Sanitaria Ospedaliera Santa Croce e Carle di 
Cuneo, Cuneo, Medicina Interna); Laura Gasbarrone, Patrizia 
Porcari, Giseppe Famularo, Maria Rosaria Sajeva (Azienda Os-
pedaliera Ospedale San Camillo, Roma, Medicina Interna 1); 
Giorgio Maniscalco, Massimo Gunelli, Daniela Tirotta (Azienda 
Ospedaliera Ospedale San Salvatore, Pesaro, Soc Medicina Inter-
na); Giuseppe Realdi, Aldo Baritussio, Francesco Frassoni (Azien-
da Ospedaliera Università di Padova, Padova, Clinica Medica I); 
Roberto Delsignore, Maria Cristina Baroni, Marianna Zardo 
(Azienda Ospedaliera Università di Parma, Parma, Clinica e Te-
rapia Medica Renato Fellin), Stefano Volpato, Sioulis Fotini 
(Azienda Ospedaliera Universitaria Ospedale Sant’Anna, Ferrara, 
Unità Operativa di Medicina Interna Gerontologia e Geriatria); 
Roberto Manfredini, Carlo Longhini, Christian Molino, Elena In-
casa (Azienda Ospedaliera Università Ospedale Sant’Anna, Fer-
rara, Unità Operativa Clinica Medica); Gianfranco Guarnieri, Mi-
chela Zanetti, Annalisa Spalluti (Azienda Ospedaliera Universita-
ria Ospedali Riuniti di Trieste, Trieste, Clinica Medica Generale e 
Terapia Medica); Giovanbattista Rini, Pasquale Mansueto, Ilenia 
Pepe (Azienda Ospedaliera Universitaria Policlinico P. Giaccone 
di Palermo, Palermo, Medicina Interna e Malattie Metaboliche); 
Giuseppe Licata, Luigi Calvo, Maria Valenti, Antonino Tuttolo-
mondo, Riccardo Di Sciacca (Azienda Ospedaliera Universitaria 
Policlinico P. Giaccone di Palermo, Palermo, Medicina Interna e 
Cardioangiologia); Salvatore Antonaci, Francesco Vella, Alessan-
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